S659-phosphorylated ACSS2 translocates to the nucleus, leading to the binding to downstream genes and acetyl-CoA production, which induces histone acetylation and gene expression for glioma development (16, 25). This evidence concerns the gene ACSS2 and central nervous system cancer.